Previous 10 | Next 10 |
Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new e-commerce ordering experience, offering clients real-time access into research model availability and pricing, as well as immediate order confirmation. The introduction of real-time ordering for Charles River’...
Charles River Laboratories International, Inc. (NYSE: CRL) will release third-quarter 2023 financial results on Wednesday, November 8 th , before the market opens. A conference call has been scheduled to discuss this information on Wednesday, November 8 th , at 8:30 a.m. ET. Investors...
Recently established regulatory guidelines make testing for pediatric indications a necessary step in oncology research and development Charles River Laboratories International, Inc. (NYSE: CRL) today announced the ability to conduct preclinical cancer research using ITCC-P4’s ...
Company selected as Energy Star Top Project of the Year for Energy Recovery System, and develops industry partnerships to align with sustainable initiatives Charles River Laboratories International, Inc. (NYSE: CRL) today announced that, while working toward previously announced environ...
2023-10-06 14:46:22 ET Summary Charles River Laboratories International, Inc. shares have fallen over 20% due to a tougher 2023 outlook and divestment of the avian vaccine business. The company's strong momentum during the pandemic led to shares peaking at $450, but they have sinc...
The platform can reduce lentiviral vector production timelines from 18 months to less than 7 months Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™ . The platform has the...
RightSource is Charles River’s purpose-built lab offering that provides accessible GMP quality control testing next to the manufacturing floor Charles River Laboratories International, Inc. (NYSE: CRL) today announced the opening of another RightSource SM facility, and fi...
2023-09-21 10:07:18 ET More on Charles River Seeking Alpha’s Quant Rating on Charles River Laboratories Historical earnings data for Charles River Laboratories Charles River Laboratories: Very Attractive After The Pullback Charles River inks deal with ...
2023-09-15 15:00:00 ET More on the markets Key Region Of Support Sides With SPY Bullish Case Market Crosswinds And Nasdaq Looking Better Than Dow The Fed's rate-hike cycle has 'most assuredly ended' -- Lawrence Fuller Fund managers finally embrace U.S. stocks...
2023-09-14 08:35:46 ET More on Charles River Seeking Alpha’s Quant Rating on Charles River Laboratories Historical earnings data for Charles River Laboratories Financial information for Charles River Laboratories Charles River Laboratories Internationa...
News, Short Squeeze, Breakout and More Instantly...
Charles River Laboratories International Inc. Company Name:
CRL Stock Symbol:
NYSE Market:
Charles River Laboratories International Inc. Website:
Lentiviral vector CDMO collaboration to support advanced cell therapies for hematological cancers Charles River Laboratories International, Inc. (NYSE: CRL) and the Gates Institute at the University of Colorado Anschutz Medical Campus today announced a lentiviral vector contract...
2024-06-18 18:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Leveraging CGT CDMO expertise to support T-cell immunotherapy clinical trial Charles River Laboratories International, Inc. (NYSE: CRL) and Captain T Cell, a spinoff from the renowned Max Delbrück Center Berlin, Germany, today announced a plasmid DNA and retrovirus vector productio...